Icon Plc (ICLR)

Price$117.12

Favorite Metrics

Price vs S&P 500 (26W)-43.94%

Price vs S&P 500 (4W)8.57%

Market Capitalization$8.94B

P/E Ratio (Annual)11.29x

All Metrics

P/CF (Annual)6.95x

Book Value / Share (Quarterly)$122.25

P/TBV (Annual)2.90x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)14.75%

Cash Flow / Share (Quarterly)$12.63

Price vs S&P 500 (YTD)-39.66%

Gross Margin (TTM)28.15%

Net Profit Margin (TTM)7.40%

EPS (TTM)$7.40

10-Day Avg Trading Volume0.92M

EPS Excl Extra (TTM)$7.40

Revenue Growth (5Y)24.17%

EPS (Annual)$9.53

ROI (Annual)6.11%

Gross Margin (Annual)29.51%

Net Profit Margin (5Y Avg)7.66%

Cash / Share (Quarterly)$6.14

P/E Basic Excl Extra (TTM)14.91x

Revenue Growth QoQ (YoY)0.63%

EPS Growth (5Y)6.71%

P/E Normalized (Annual)11.29x

ROA (Last FY)4.69%

Revenue Growth TTM (YoY)-2.46%

EBITD / Share (TTM)$14.98

ROE (5Y Avg)8.15%

Operating Margin (TTM)10.03%

Cash Flow / Share (Annual)$13.85

P/B Ratio0.96x

P/B Ratio (Quarterly)1.43x

Net Income / Employee (Annual)$0

EV / Revenue (TTM)1.47x

Net Interest Coverage (TTM)4.80x

ROA (TTM)3.59%

EPS Growth QoQ (YoY)-98.72%

EV / EBITDA (TTM)9.89x

EPS Incl Extra (Annual)$9.53

Current Ratio (Annual)1.26x

Quick Ratio (Quarterly)1.02x

3-Month Avg Trading Volume1.52M

52-Week Price Return-15.93%

EV / Free Cash Flow (Annual)10.62x

P/E Incl Extra (TTM)14.91x

Revenue / Employee (TTM)$0

Tangible BV / Share (Quarterly)$77.93

P/S Ratio (Annual)1.08x

Asset Turnover (Annual)0.49x

52-Week High$211.00

Operating Margin (5Y Avg)11.24%

EPS Excl Extra (Annual)$9.53

CapEx CAGR (5Y)27.13%

Tangible BV CAGR (5Y)30.91%

26-Week Price Return-37.05%

Quick Ratio (Annual)1.21x

13-Week Price Return-35.85%

Total Debt / Equity (Annual)0.36x

Current Ratio (Quarterly)1.06x

Enterprise Value$11,878.114

Revenue / Share Growth (5Y)14.06%

Asset Turnover (TTM)0.49x

Book Value / Share Growth (5Y)31.51%

Revenue / Employee (Annual)$0

Pretax Margin (Annual)10.50%

Cash / Share (Annual)$6.67

3-Month Return Std Dev100.62%

Gross Margin (5Y Avg)28.94%

Net Income / Employee (TTM)$0

EBITDA CAGR (5Y)26.23%

EBITDA Interim CAGR (5Y)8.13%

ROE (Last FY)8.31%

Net Interest Coverage (Annual)4.26x

EPS Basic Excl Extra (Annual)$9.53

P/FCF (TTM)9.27x

Receivables Turnover (TTM)3.00x

EV / Free Cash Flow (TTM)12.32x

Total Debt / Equity (Quarterly)0.37x

EPS Incl Extra (TTM)$7.40

Receivables Turnover (Annual)3.05x

ROI (TTM)4.65%

P/S Ratio (TTM)1.10x

Pretax Margin (5Y Avg)8.55%

Revenue / Share (Annual)$99.74

Tangible BV / Share (Annual)$73.84

Forward P/E9.01x

Free OCF CAGR (5Y)25.32%

Price vs S&P 500 (52W)-50.57%

P/E Ratio (TTM)14.91x

EPS Growth TTM (YoY)-17.75%

Year-to-Date Return-35.73%

5-Day Price Return3.59%

EPS Normalized (Annual)$9.53

ROA (5Y Avg)4.36%

Net Profit Margin (Annual)9.56%

Month-to-Date Return5.84%

Cash Flow / Share (TTM)$13.22

EBITD / Share (Annual)$19.10

EPS Growth (3Y)61.82%

Operating Margin (Annual)13.26%

LT Debt / Equity (Annual)0.36x

P/CF (TTM)7.84x

ROI (5Y Avg)6.18%

P/E Excl Extra (TTM)14.91x

LT Debt / Equity (Quarterly)0.31x

EPS Basic Excl Extra (TTM)$7.40

P/TBV (Quarterly)2.25x

P/B Ratio (Annual)1.82x

Pretax Margin (TTM)7.67%

Book Value / Share (Annual)$117.92

Price vs S&P 500 (13W)-38.23%

Net Margin Growth (5Y)-6.43%

Beta1.25x

P/FCF (Annual)7.99x

Revenue / Share (TTM)$103.77

ROE (TTM)6.32%

52-Week Low$66.57

Analyst Recommendations

Jan 2026

Feb 2026

Mar 2026

Apr 2026

3.75

3.71

3.75

About

Icon is a global contract research organization providing clinical trial and drug development services to pharmaceutical, biotechnology, and medical device companies. The company derives the majority of its revenue from clinical research operations, complemented by laboratory and imaging services. Icon is headquartered in Dublin, Ireland.